Equillium EBITDA vs. Revenue

EQ Stock  USD 0.75  0.02  2.60%   
Taking into consideration Equillium's profitability measurements, Equillium may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Equillium's ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-12.1 M
Current Value
-12.7 M
Quarterly Volatility
15.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Equillium's Days Sales Outstanding is relatively stable compared to the past year. As of 11/29/2024, EV To Sales is likely to grow to 0.08, while Operating Cash Flow Sales Ratio is likely to drop (0.63). At this time, Equillium's Accumulated Other Comprehensive Income is relatively stable compared to the past year. As of 11/29/2024, Interest Income is likely to grow to about 2.1 M, while Income Before Tax is likely to drop (13.4 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.790.9965
Significantly Down
Slightly volatile
For Equillium profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Equillium to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Equillium utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Equillium's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Equillium over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.12)
Revenue Per Share
1.213
Quarterly Revenue Growth
0.518
Return On Assets
(0.12)
Return On Equity
(0.34)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Equillium Revenue vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Equillium's current stock value. Our valuation model uses many indicators to compare Equillium value to that of its competitors to determine the firm's financial worth.
Equillium is one of the top stocks in ebitda category among its peers. It also is rated as one of the top companies in revenue category among its peers . Equillium reported last year EBITDA of (12.14 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Equillium by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Equillium Revenue vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Equillium

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(12.14 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Equillium

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
36.08 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Equillium Revenue vs Competition

Equillium is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 50.41 Million. Equillium totals roughly 36.08 Million in revenue claiming about 72% of equities under Health Care industry.

Equillium Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Equillium, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Equillium will eventually generate negative long term returns. The profitability progress is the general direction of Equillium's change in net profit over the period of time. It can combine multiple indicators of Equillium, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income140 K147 K
Interest IncomeM2.1 M
Operating Income-14.5 M-15.2 M
Net Loss-8.2 M-8.6 M
Income Before Tax-12.8 M-13.4 M
Total Other Income Expense Net1.8 M1.9 M
Net Loss-56.2 M-53.4 M
Net Loss-13.3 M-14 M
Income Tax Expense580 K551 K
Net Interest Income1.3 M1.3 M
Non Operating Income Net Other-289.8 K-275.3 K
Change To Netincome32.5 M34.1 M
Net Loss(0.38)(0.40)
Income Quality 1.63  1.72 
Net Income Per E B T 1.05  0.92 

Equillium Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Equillium. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Equillium position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Equillium's important profitability drivers and their relationship over time.

Use Equillium in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Equillium Pair Trading

Equillium Pair Trading Analysis

The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Equillium position

In addition to having Equillium in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Processed Foods Thematic Idea Now

Processed Foods
Processed Foods Theme
Companies producing and distributing processed foods to retail sectors. The Processed Foods theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Processed Foods Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Equillium Stock Analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.